Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus (RSV)

Explore clinical trials studying Respiratory Syncytial Virus (RSV). Study availability and eligibility vary by location and protocol.

62 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus (RSV) trial results

Recruiting

A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults

NCT07764237

Conditions
Human Metapneuomovirus (hMPV), Respiratory Syncytial Virus (RSV)
Locations
  • Diex Recherche Quebec Québec, Quebec, Canada
  • Diex Recherche Victoraville Victoriaville, Quebec, Canada
  • MAC Clinical Research Manchester, Greater Manchester, United Kingdom
  • Southampton General Hospital, NHS Southampton, Hampshire, United Kingdom
View Trial Details
Recruiting

A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF

NCT07653100

Conditions
Respiratory Syncytial Virus (RSV)
Locations
  • King George Hospital Visakhapatnam, Andhra Pradesh, India
  • BGS Global Institute of Medical Sciences (BGSGIMS) Bangalore, Karnataka, India
  • Radhakrishna Multispeciality Hospital and IVF Center Bangalore, Karnataka, India
  • Belagavi Institute of Medical Sciences - Belagavi Belagavi, Karnataka, India
View all 13 locations
View Trial Details
Recruiting

A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus

NCT07482657

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +7 more
Locations
  • Center of Excellence for Pediatric Infectious Diseases and Vaccines Faculty of Medicine, Chulalongkorn University (CE-PID) Bangkok, Thailand
  • Nakornping Hospital Chiang Mai, Thailand
  • Maharaj Nakorn Chiang Mai Hospital Chiang Mai, Thailand
  • Chiangrai Prachanukroh Hospital Chiang Rai, Thailand
View Trial Details
Recruiting

Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

NCT07516418

Conditions
Infections, Influenza A(H5N1), Influenza, Human, +10 more
Locations
  • Site # 0361002 Griffith, Queensland, Australia
  • Site # 0361001 Herston, Queensland, Australia
  • Site # 0361003 Morayfield, Queensland, Australia
  • Site # 0361005 Sippy Downs, Queensland, Australia
View Trial Details
Recruiting

Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)

NCT07272434

Conditions
Respiratory Syncytial Virus (RSV)
Locations
  • Guangdong Provincial Center for Disease Control and Prevention Guangzhou, Guangdong, China
  • Hebei Provincial Center for Disease Control and Prevention Shijiazhuang, Hebei, China
  • Henan Center for Disease Control and Prevention Zhengzhou, Henan, China
  • Hubei Provincial Center for Disease Control and Prevention Wuhan, Hubei, China
View Trial Details

Related conditions